Methotrexate combined with omalizumab for difficult to treat urticaria: a further step-up treatment?

P. Garbayo-Salmons (Lead / Corresponding author), S. Butt, Robert S. Dawe

Research output: Contribution to journalArticle

Abstract

Classically, chronic urticaria has been treated following a stepwise approach where Omalizumab and other immunosuppressants occupy the last step. Omalizumab and Methotrexate have both been used separately for the treatment of urticaria1,2 . We believe combination treatment with both agents is a valuable alternative for refractory chronic urticaria and other related diseases such as urticarial vasculitis. Here we report on two patients who responded to the combination treatment.

Original languageEnglish
JournalClinical and Experimental Dermatology
DOIs
Publication statusE-pub ahead of print - 29 Jun 2020

Fingerprint Dive into the research topics of 'Methotrexate combined with omalizumab for difficult to treat urticaria: a further step-up treatment?'. Together they form a unique fingerprint.

  • Cite this